{
    "abstract": "The aim of this paper was to analyze, retrospectively, in prostate cancer patients treated in our Centre with external beam radiotherapy, the prognostic factors and their impact on the outcome in terms of cancer-specific survival (CSS), biochemical disease-free survival (BDFS) and clinical disease-free survival (CDFS).\nFrom October 1999 and March 2012, 1080 patients were treated with radiotherapy at our Institution: 87% of them were classified as \u2264cT2, 83% had a Gleason Score (GS) \u22647, their mean of iPSA was 18 ng/mL, and the rate of clinical positive nodes was 1%. The mean follow-up was 81 months.\nThe statistically significant prognostic factors for all groups of patients at both, univariate and multivariate analysis, were the GS and the iPSA. In intermediate- and high- or very-high-risk patients at multivariate analysis other prognostic factors for CSS were positive nodes on computed tomography (CT) scan and rectal preparation during the treatment; for BDFS, the prognostic factors were patient risk classification, positive lymph nodes on CT scan and rectal/bladder preparation; for CDFS, the prognostic factors were the number of positive core on biopsy (P=0.003), positive lymph nodes on CT scan, and radiotherapy (RT) dose. In high/very-high risk patient group at multivariate analysis other prognostic factors for CSS were clinical/radiological stage and RT dose, for BDFS they were adjuvant hormone therapy, clinical/radiological stage, and RT dose >77.7 Gy, and for CDFS they were clinical/radiological stage and RT dose >77.7 Gy.\nThe results of this study confirm the prognostic factors described in the recent literature, with the addition of rectal/bladder preparation, generally known for its effect on toxicity but not yet on outcome.",
    "authors": [
        {
            "affiliation": "Radiotherapy Unit, Candiolo Cancer Institute - FPO, IRCCS, Turin, Italy - elisabetta.garibaldi@ircc.it.",
            "firstname": "Elisabetta",
            "initials": "E",
            "lastname": "Garibaldi"
        },
        {
            "affiliation": "Department of Radiotherapy, University of Sassari, Sassari, Italy.",
            "firstname": "Domenico",
            "initials": "D",
            "lastname": "Gabriele"
        },
        {
            "affiliation": "Medical Physics Unit, Candiolo Cancer Institute - FPO, IRCCS, Turin, Italy.",
            "firstname": "Angelo",
            "initials": "A",
            "lastname": "Maggio"
        },
        {
            "affiliation": "Radiotherapy Unit, Candiolo Cancer Institute - FPO, IRCCS, Turin, Italy.",
            "firstname": "Elena",
            "initials": "E",
            "lastname": "Delmastro"
        },
        {
            "affiliation": "Department of Radiotherapy, University of Sassari, Sassari, Italy.",
            "firstname": "Monica",
            "initials": "M",
            "lastname": "Garibaldi"
        },
        {
            "affiliation": "Radiology Unit, Candiolo Cancer Institute - FPO, IRCCS, Turin, Italy.",
            "firstname": "Filippo",
            "initials": "F",
            "lastname": "Russo"
        },
        {
            "affiliation": "Medical Physics Unit, Candiolo Cancer Institute - FPO, IRCCS, Turin, Italy.",
            "firstname": "Sara",
            "initials": "S",
            "lastname": "Bresciani"
        },
        {
            "affiliation": "Medical Physics Unit, Candiolo Cancer Institute - FPO, IRCCS, Turin, Italy.",
            "firstname": "Michele",
            "initials": "M",
            "lastname": "Stasi"
        },
        {
            "affiliation": "Radiotherapy Unit, Candiolo Cancer Institute - FPO, IRCCS, Turin, Italy.",
            "firstname": "Pietro",
            "initials": "P",
            "lastname": "Gabriele"
        }
    ],
    "conclusions": null,
    "copyrights": null,
    "doi": "10.23736/S0031-0808.17.03232-3",
    "journal": "Panminerva medica",
    "keywords": [],
    "methods": null,
    "publication_date": "2017-03-04",
    "pubmed_id": "28256120",
    "results": "The statistically significant prognostic factors for all groups of patients at both, univariate and multivariate analysis, were the GS and the iPSA. In intermediate- and high- or very-high-risk patients at multivariate analysis other prognostic factors for CSS were positive nodes on computed tomography (CT) scan and rectal preparation during the treatment; for BDFS, the prognostic factors were patient risk classification, positive lymph nodes on CT scan and rectal/bladder preparation; for CDFS, the prognostic factors were the number of positive core on biopsy (P=0.003), positive lymph nodes on CT scan, and radiotherapy (RT) dose. In high/very-high risk patient group at multivariate analysis other prognostic factors for CSS were clinical/radiological stage and RT dose, for BDFS they were adjuvant hormone therapy, clinical/radiological stage, and RT dose >77.7 Gy, and for CDFS they were clinical/radiological stage and RT dose >77.7 Gy.",
    "title": "Prognostic factors in prostate cancer patients treated by radical external beam radiotherapy.",
    "xml": "<Element 'PubmedArticle' at 0x788504a77380>"
}